Showing results (271-280 of 282) with videos related to
Sort By:
Pageof 29
Cell|March 18, 2025
Ligand-induced ubiquitination unleashes LAG3 immune checkpoint function by hindering membrane sequestration of signaling motifsYong Jiang, Anran Dai, Yuwei Huang, et al.Cell Reports. Medicine|December 7, 2021
People critically ill with COVID-19 exhibit peripheral immune profiles predictive of mortality and reflective of SARS-CoV-2 lung viral burdenAnthony R Cillo, Ashwin Somasundaram, Feng Shan, et al.Biorxiv : the Preprint Server for Biology|February 17, 2021
Bifurcated monocyte states are predictive of mortality in severe COVID-19Anthony R Cillo, Ashwin Somasundaram, Feng Shan, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 8, 2024
Lymphocyte-Activation Gene 3 Facilitates Pathological Tau Neuron-to-Neuron TransmissionChan Chen, Ramhari Kumbhar, Hu Wang, et al.Science Translational Medicine|December 8, 2021
Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancerChristopher A Chuckran, Anthony R Cillo, Jessica Moskovitz, et al.Cell|April 7, 2023
Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatmentMackenzie J Bender, Alex C McPherson, Catherine M Phelps, et al.Science Immunology|January 16, 2021
Inhibitory signaling sustains a distinct early memory CD8+ T cell precursor that is resistant to DNA damageJonathan B Johnnidis, Yuki Muroyama, Shin Foong Ngiow, et al.Biorxiv : the Preprint Server for Biology|April 22, 2024
All-trans retinoic acid induces durable tumor immunity in IDH-mutant gliomas by rescuing transcriptional repression of the CRBP1-retinoic acid axisAparna Rao, Xiaoran Zhang, Anthony R Cillo, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 28, 2021
Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case StudyMatthew K Hensley, William G Bain, Jana Jacobs, et al.Science (New York, N.Y.)|October 7, 2016
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3Xiaobo Mao, Michael Tianhao Ou, Senthilkumar S Karuppagounder, et al.Pageof 29